Introduction: Cervical cancer is a serious condition that affects thousands of women worldwide, with a higher prevalence in developing countries. It is the fourth most common type of cancer among women. Prevention, along with early diagnosis and proper disease management, is essential to ensure a better prognosis and quality of life for patients. This makes it a concerning reality that requires constant monitoring, supported by epidemiological data. Objectives: To analyze the epidemiological profile of hospital morbidity due to malignant neoplasm of the cervix across the five regions of Brazil, from 2020 to 2024. Methods: This is an ecological, observational, and descriptive study with a quantitative approach, based on secondary data obtained from the Department of Informatics of the Unified Health System (SIH/SUS) regarding the epidemiological profile of morbidity due to malignant cervical neoplasm in Brazil from 2020 to 2024. Data were collected in April 2025. The following variables were analyzed: region and age group. Results: During the analyzed period, a total of 130,388 hospitalizations were recorded, distributed across the five regions of the country: 10,670 (8.18%) patients were from the North region, 33,908 (26%) from the Northeast, 51,201 (39.28%) from the Southeast, 24,809 (19.02%) from the South, and 9,782 (7.5%) from the Central-West. In the 0 to 19 age group, 186 cases (0.14%) were reported; among individuals aged 20 to 59 years, a more significant number of cases was observed, totaling 100,749 (77.26%); and in the 60 to 80 years or older age group, 29,453 cases (22.58%) were recorded. These data indicate that the majority of hospitalizations are concentrated in the young adult population and show a progressive increase trend of approximately 36.6% from 2020 to 2024 across all evaluated regions, highlighting the importance of preventive strategies and early diagnosis, especially in the most affected population. Furthermore, regional disparities reveal inequalities in access to healthcare services, diagnosis, and treatment, emphasizing the need for specific public policies that promote equity in cancer care throughout the country. Understanding regional and age-related hospitalization patterns is essential for identifying priority areas for intervention, enabling the development of more effective public health actions.Conclusion: The results of this study highlight a significant burden of morbidity due to malignant neoplasms of the cervix in Brazil between 2020 and 2024, with a predominance of hospitalizations among young adult women and marked variations across different regions of the country. The increasing trend in hospitalization rates, particularly in the Southeast and Northeast regions, underscores the urgency of coordinated actions that prioritize prevention, regular screening, and early diagnosis. Furthermore, the identified regional disparities reveal the need for public policies that promote greater equity in access to healthcare services, especially in historically underserved areas.Understanding age and regional patterns is essential for guiding more effective interventions and reducing the morbidity and mortality associated with the disease.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
